Authors
Martha Meibom, Jeppe K Petersen, Victoria Mikkelsen, Louise Marqvard Sørensen, Jonas Agerlund Povlsen, Christian Juhl Terkelsen, Ashkan Eftekhari, Ole de Backer, Morten Schou, Lars Køber, Emil Fosbøl
Published in
European heart journal. Valvular and structural heart disease. Volume 2. Issue 3. Pages xwag074. Epub Aug 17, 2026.
Abstract
Prognosis after transcatheter aortic valve implantation (TAVI) keeps improving, yet some high-risk groups persist, with chronic kidney disease being one. Contemporary data on the prognostic importance of pre-TAVI kidney function are sparse, leaving uncertainty regarding which patients derive limited benefit from TAVI.
To assess the association between pre-procedural kidney function and long-term outcomes in TAVI patients.
We used Danish nationwide registries to identify patients with aortic stenosis undergoing TAVI between 2015 and 2022. Patients were categorized by baseline eGFR into ≥60, 30-59, and <30 mL/min/1.73 m2 or recent dialysis. We examined one-year all-cause mortality and hospitalization burden after TAVI and estimated relative risks using multivariable Cox and logistic regression.
We included 3888 (60.7%) patients with eGFR ≥60 (58.4% male; median age, 80 years), 2185 (34.1%) with eGFR 30-59 (55.5% male; median age, 83), and 336 (5.2%) with eGFR <30 or recent dialysis (58.0% male; median age, 81).One-year cumulative incidence of all-cause mortality was 5.6% for eGFR ≥60, 9.1% for eGFR 30-59, and 19.6% for eGFR <30 or dialysis. Adjusted hazard ratio was significantly higher for eGFR 30-59 (aHR, 1.45; 95% CI, 1.19-1.78, p =0 .0003) and eGFR <30 or dialysis (aHR, 3.07; 95% CI, 2.32-4.08, p < .0001) than eGFR ≥60. Cumulative rehospitalization exceding14 days after TAVI was most frequent among patients with eGFR <30 or dialysis (18.4%).
We observed a stepwise association between pre-TAVI kidney function and post-TAVI one-year mortality as well as hospitalization burden. Kidney impairment potentially has substantial prognostic impact and should be incorporated into lifetime management of patients undergoing TAVI.
PMID:
43053878
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0